Lili Yang is an associate professor of microbiology, immunology, and molecular genetics at the University of California, Los Angeles (UCLA). She and her colleagues developed allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy. In this Q&A, she describes her research journey and her opinions about the cancer immunotherapy research field.
Copyright © 2022.